Issue 36, 2021

Leveraging BODIPY nanomaterials for enhanced tumor photothermal therapy

Abstract

In the past ten years, photothermal therapy (PTT) has attracted widespread attention in tumor treatment due to its non-invasiveness and little side effects. PTT utilizes heat produced by photothermal agents under the irradiation of near-infrared light to kill tumor cells. Boron-dipyrromethene (BODIPY), an organic phototherapy agent, has been widely used in tumor phototherapy due to its higher molar extinction coefficient, robust photostability and good phototherapy effect. However, there are some issues in the application of BODIPY for tumor PTT, such as low photothermal conversion efficiency and short absorption wavelength. In this review, we focus on the latest development of BODIPY nanomaterials for overcoming the above problems and enhancing the PTT effect.

Graphical abstract: Leveraging BODIPY nanomaterials for enhanced tumor photothermal therapy

Article information

Article type
Review Article
Submitted
16 Agd 2021
Accepted
06 Qad 2021
First published
08 Qad 2021

J. Mater. Chem. B, 2021,9, 7318-7327

Leveraging BODIPY nanomaterials for enhanced tumor photothermal therapy

C. Ma, T. Zhang and Z. Xie, J. Mater. Chem. B, 2021, 9, 7318 DOI: 10.1039/D1TB00855B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements